Clinical trials
Completed Lymphoma, T-Cell trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2009 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2018 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Seagen Inc. | 2 |
| AHS Cancer Control Alberta | 1 |
| Acrotech Biopharma Inc. | 1 |
| BeiGene | 1 |
| Prelude Therapeutics | 1 |
| Rigel Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell | 10 |
| Lymphoma | 5 |
| Lymphoma, Large-Cell, Anaplastic | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Hematologic Diseases | 2 |
| Hematologic Neoplasms | 2 |
| Immunoblastic Lymphadenopathy | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, Extranodal NK-T-Cell | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.